119 related articles for article (PubMed ID: 37414265)
1. Role of standard HLA mismatch in modifying associations between non-pharmacologic risk factors and solid organ malignancy after kidney transplantation.
Santos AH; Mehta R; Ibrahim H; Leghrouz MA; Alquadan K; Belal A; Lee JJ; Wen X
Transpl Immunol; 2023 Oct; 80():101885. PubMed ID: 37414265
[TBL] [Abstract][Full Text] [Related]
2. Association of HLA mismatch and MTOR inhibitor regimens with malignancy and mortality after kidney transplantation.
Santos AH; Chen C; Leghrouz MA; Bueno EP; Lee JJ; Wen X
Transpl Immunol; 2021 Jun; 66():101391. PubMed ID: 33838299
[TBL] [Abstract][Full Text] [Related]
3. HLA-DQ Mismatching and Kidney Transplant Outcomes.
Leeaphorn N; Pena JRA; Thamcharoen N; Khankin EV; Pavlakis M; Cardarelli F
Clin J Am Soc Nephrol; 2018 May; 13(5):763-771. PubMed ID: 29685925
[TBL] [Abstract][Full Text] [Related]
4. What is the impact of human leukocyte antigen mismatching on graft survival and mortality in renal transplantation? A meta-analysis of 23 cohort studies involving 486,608 recipients.
Shi X; Lv J; Han W; Zhong X; Xie X; Su B; Ding J
BMC Nephrol; 2018 May; 19(1):116. PubMed ID: 29776389
[TBL] [Abstract][Full Text] [Related]
5. Association of HLA Antigen Mismatch With Risk of Developing Skin Cancer After Solid-Organ Transplant.
Gao Y; Twigg AR; Hirose R; Roll GR; Nowacki AS; Maytin EV; Vidimos AT; Rajalingam R; Arron ST
JAMA Dermatol; 2019 Mar; 155(3):307-314. PubMed ID: 30673077
[TBL] [Abstract][Full Text] [Related]
6. Effects of antibody induction on transplant outcomes in human leukocyte antigen zero-mismatch deceased donor kidney recipients.
Kuo HT; Huang E; Emami S; Pham PT; Wilkinson AH; Danovitch GM; Bunnapradist S
Transplantation; 2012 Mar; 93(5):493-502. PubMed ID: 22306574
[TBL] [Abstract][Full Text] [Related]
7. Pre-transplant HLA Antibodies and Delayed Graft Function in the Current Era of Kidney Transplantation.
Morath C; Döhler B; Kälble F; Pego da Silva L; Echterdiek F; Schwenger V; Živčić-Ćosić S; Katalinić N; Kuypers D; Benöhr P; Haubitz M; Ziemann M; Nitschke M; Emmerich F; Pisarski P; Karakizlis H; Weimer R; Ruhenstroth A; Scherer S; Tran TH; Mehrabi A; Zeier M; Süsal C
Front Immunol; 2020; 11():1886. PubMed ID: 32983110
[TBL] [Abstract][Full Text] [Related]
8. Induction Type and Outcomes in HLA-DR Mismatch Kidney Transplantation.
Sureshkumar KK; Chopra B
Transplant Proc; 2019; 51(6):1796-1800. PubMed ID: 31399165
[TBL] [Abstract][Full Text] [Related]
9. HLA gene dosage effect on renal allograft survival.
Kim KH; Jung HY; Choi JY; Cho JH; Park SH; Kim YL; Kim HK; Huh S; Won DI; Kim CD
Transplant Proc; 2015 Apr; 47(3):635-9. PubMed ID: 25891701
[TBL] [Abstract][Full Text] [Related]
10. Association of mismatches for HLA-DR with incidence of posttransplant hip fracture in kidney transplant recipients.
Opelz G; Döhler B
Transplantation; 2011 Jan; 91(1):65-9. PubMed ID: 21452411
[TBL] [Abstract][Full Text] [Related]
11. A Kidney Graft Survival Calculator that Accounts for Mismatches in Age, Sex, HLA, and Body Size.
Ashby VB; Leichtman AB; Rees MA; Song PX; Bray M; Wang W; Kalbfleisch JD
Clin J Am Soc Nephrol; 2017 Jul; 12(7):1148-1160. PubMed ID: 28596416
[TBL] [Abstract][Full Text] [Related]
12. The Risk of Transplant Failure With HLA Mismatch in First Adult Kidney Allografts From Deceased Donors.
Williams RC; Opelz G; McGarvey CJ; Weil EJ; Chakkera HA
Transplantation; 2016 May; 100(5):1094-102. PubMed ID: 26901078
[TBL] [Abstract][Full Text] [Related]
13. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
[TBL] [Abstract][Full Text] [Related]
14. Impact of HLA mismatch at first kidney transplant on lifetime with graft function in young recipients.
Foster BJ; Dahhou M; Zhang X; Platt RW; Smith JM; Hanley JA
Am J Transplant; 2014 Apr; 14(4):876-85. PubMed ID: 24612783
[TBL] [Abstract][Full Text] [Related]
15. The impact of human leukocyte antigen mismatching on sensitization rates and subsequent retransplantation after first graft failure in pediatric renal transplant recipients.
Gralla J; Tong S; Wiseman AC
Transplantation; 2013 May; 95(10):1218-24. PubMed ID: 23478360
[TBL] [Abstract][Full Text] [Related]
16. Risk Factors Affecting Graft and Patient Survivals After Transplantation From Deceased Donors in a Developing Country: A Single-Center Experience.
Ayar Y; Ersoy A; Ocakoglu G; Yildiz A; Oruc A; Soyak H; Calapkulu M; Sahin AB; Topal NB; Okeer E; Coskun B; Kaygisiz O; Kordan Y; Vuruskan H
Transplant Proc; 2017 Mar; 49(2):270-277. PubMed ID: 28219583
[TBL] [Abstract][Full Text] [Related]
17. The HLA-matching effect in different cohorts of kidney transplant recipients: 10 years later.
Sasaki N; Idica A
Clin Transpl; 2010; ():261-82. PubMed ID: 21696046
[TBL] [Abstract][Full Text] [Related]
18. HLA Class II Antibodies at the Time of Kidney Transplantation and Cardiovascular Outcome: A Retrospective Cohort Study.
Malfait T; Emonds MP; Daniëls L; Nagler EV; Van Biesen W; Van Laecke S
Transplantation; 2020 Apr; 104(4):823-834. PubMed ID: 31369517
[TBL] [Abstract][Full Text] [Related]
19. Human leukocyte antigen eplet mismatching is associated with increased risk of graft loss and rejection after pediatric heart transplant.
Albers EL; Friedland-Little JM; Hong BJ; Kemna MS; Warner P; Law YM
Pediatr Transplant; 2022 Feb; 26(1):e14126. PubMed ID: 34476876
[TBL] [Abstract][Full Text] [Related]
20. Pretransplant angiotensin II type 1-receptor antibodies are a risk factor for earlier detection of de novo HLA donor-specific antibodies.
Cuevas E; Arreola-Guerra JM; Hernández-Méndez EA; Salcedo I; Castelán N; Uribe-Uribe NO; Vilatobá M; Contreras-Saldívar AG; Sánchez-Cedillo AI; Ramírez JB; de Rungs D; Granados J; Morales-Buenrostro LE; Alberú J
Nephrol Dial Transplant; 2016 Oct; 31(10):1738-45. PubMed ID: 27220757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
